Type 2 diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia in which the body becomes resistant to the normal effects of insulin and slowly loses the capacity to produce insulin in the pancreas. As a result, the β cells in the pancreas respond by producing more amount of insulin, in order to achieve some degree of management of the blood glucose levels. Thus, this overproduction of insulin causes β cells to wear themselves out (Cerf, 2013) .
Different enzymes act in diabetic pathway each having its specific role in the progression of the disease. Each enzyme plays its specific role as they are involved in the pathogenesis of the disease, control and modulate auto-phosphorylation of insulin receptors, and uptake of glucose by glucose transporter type 4 (GLUT4; Kitada et al., 2010) . The principle mediator for glucose uptake in the cells is an insulin-regulated glucose transporter known as GLUT4 (Huang & Czech, 2007) .
In this review, the role of these enzymes in the pathogenesis of diabetes is discussed. These enzymes could be targeted for treating this metabolic disorder. This review summarizes the inhibitors of different enzymes in diabetes pathways and natural products that target these enzymes. Moreover, it will provide very useful material for improving the competence of rational antidiabetic drug design (Figures 1-4) .
| METHODS
The data about enzyme inhibitors acting on different diabetes pathways were searched and obtained using databases such as PubMed, Science Direct, Scopus, research gate, and Google Scholar. The plant's scientific name was validated using the plant name index databases, Plantlist.org.
| Activation of protein kinases and phosphatases
There is a variety of signaling pathways for insulin to produce its effect (Gum et al., 2003) . Pancreatic β cells secrete insulin in response to the upsurge in glucose concentrations in the blood. Binding of insulin to the extracellular alpha subunits triggers the activation of the intrinsic tyrosine kinases (Fountas, Diamantopoulos, & Tsatsoulis, 2015) . Insulin receptor substrate is phosphorylated by tyrosine kinases. This series of phosphorylation on the signaling molecules causes the uptake of glucose into cells by the glucose transporter GLUT4. Protein tyrosine phosphatase IB (PTP1B) functions to inactivate the insulin receptor and dephosphorylate the insulin receptor substrate. PTP1B negatively regulates the insulin receptor and its substrates, such as insulin receptor substrates 1 and 2, by dephosphorylating them and serves as the negative regulator of insulin signaling (LeRoith, Taylor, & Olefsky, 2004 ; Tables 1, 2).
| Activation of polyol pathway
Aldose reductase AKR 1 B 1 is a member of monomeric nicotinamide adenine dinucleotide hydrogen phosphate (NADPH) dependent oxidoreductases with the molecular weight of 37kD. The reduction of glucose to sorbitol is accompanied by the oxidation of NADPH to NADP+ via AKR 1 B 1 (Dunlop, 2000) . In a state of hyperglycemia, the affinity of aldose reductase for glucose increases initiating much sorbitol to accumulate more NADPH is consumed and leaving less NADPH for other processes of cellular metabolism (El-Kabbani & Podjarny, 2007) . After sorbitol has been formed, it does not easily diffuse across cell membranes; this intracellular buildup of sorbitol may be a reason in the etiology of diabetic complications. Higher concentration of cellular sorbitol results in osmotic stresses on cells and is then associated mainly in microvascular destruction to the retina, kidney, and nervous systems (Gabbay, 1973) .
The end product of the polyol pathway is fructose which enters in the hexosamine pathway (Shimoshige, Enomoto, Aoki, Matsuoka, & Kaneko, 2010) leading to activation of protein kinase C and advanced glycation end product (AGE). The oxidation of NADH by NADH oxidase produces reactive oxygen species, which can attack the mitochondrial membrane and results in mitochondrial dysfunction.
| Advanced glycation end products (AGEs)
After effects of long-term diabetes results in accumulation of AGEs in the kidneys. The receptors of AGEs exist either alone or grouped with other ligands. When the AGEs receptors are activated, it results in promotion of damage of kidney, inflammatory conditions, and fibrosis, which are related with diabetic nephropathy.
In the diabetic kidney, the effect of AGEs is to synergize and potentiate the actions of other pathogenic mediators such as oxidative stress, protein kinase C, and renin-angiotensin system activation. It results in the advancement of kidney disease. It is found that direct exposure to AGEs results in similar lesions as seen in diabetic nephropathy. The innate defense against AGEs buildup exist, but in diabetes, this ability is reduced. A variety of agents have been tested to reduce the AGEs. Many of such agents proved effective but their clinical utility remains unproven (Thomas, 2011) . FIGURE 1 Hyperglycemia-induced damage (Kitada et al., 2010) FIGURE 2 PTP1B in insulin transduction pathway (Asante & Kennedy, 2003 In the hyperglycemic state, glucose forms covalent bonds with the proteins via a nonenzymatic process, that is, glycation resulting in the formation of AGEs. These are involved in transcription of genes and alter the cellular signaling causing cellular dysfunction (Goldin, Beckman, Schmidt, & Creager, 2006) . These AGEs play the central role in the pathogenesis of diabetic complications including diabetic nephropathy, retinopathy, and neuropathy (Singh, Bali, Singh, & Jaggi, 2014) .
| Activation of the hexosamine pathway
When the concentration of glucose is elevated in a cell, the process of glycolysis takes place to metabolize glucose. On the other hand, fructose-6 phosphate diverts into a signaling pathway where it is converted by enzyme glutamine fructose-6 phosphate amidotransferase into glucosamine-6-phosphate and lastly to uridine diphosphate Nacetyl glucosamine. N-acetyl glucosamine gets put onto serine and threonine residues of transcription factors, that is, transforming growth factor-1 and plasminogen activator inhibitor-1 resulting in microvascular complications (Fantus, Goldberg, & Whiteside, 2006) .
| Activation of alpha-glucosidase
The alpha-glucosidase is an important enzyme found in human body.
Inhibition of this enzyme in intestine results in delayed carbohydrates digestion. It also results in lowering of glucose level after meal.
Consequently, the mechanism of alpha-glucosidase inhibition signifies the pharmacological optimization of the nutritional principle of late carbohydrate absorption. Acarbose when given orally inhibited the enzymes alpha-glucosidase in the brush border of the small intestines and reduces the rate of digestion of complex carbohydrates. So the inhibitors of alpha-glucosidase work in a similar fashion and retard the glycation of proteins and therefore reduced the glycated hemoglobin and glycation end products in collagen. The result is the improvement of biochemical parameters and act against the neuropathy and diabetic nephropathy. Therefore, treatment of diabetic animals with alpha-glucosidase inhibitors improves the metabolic state and prevents the onset of diabetic complications (AG, 1994) . Alphaglucosidase is found in the brush border of intestinal mucosa where they catalyze the end product of digestion into carbohydrates. It is involved in postprandial hyperglycemia (Lebovitz, 1997) .
| Renin Angiotensin Aldosterone System (RAAS)
RAAS is a hormonal system that produces physiologically active Angiotensin II to regulate blood pressure and fluid and electrolyte homeostasis. Moreover, many tissues have been found to have their own local RAAS that can express many of the components of RAAS at these site in order to manipulate the expression of receptors (Cooper, 2004) . Genetic variations in RAAS increase the risk of hypertension, premature atherosclerosis, and incidence of Type 2 diabetes. Increase glucose metabolism and inhibited alpha-glucosidase (Toyomizu et al., 1993) 12 Andrographis paniculata Acanthaceae
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| Glucokinase in diabetes
The enzyme glucokinase plays an important role in glucose hemostasis. It is regulated by a protein known as glucokinase regulatory protein (Matschinsky et al., 2011) . In the pancreas, glucokinase activity is regulated by transcriptional factors, whereas in the liver, it is regulated by glucokinase regulatory protein. Glucokinase catalyzes the first step in glucose metabolism and mutation in this enzyme is related to maturity-onset diabetes of young. Increase carbohydrate diet caused high levels of this enzyme and increased glucose tolerance (Slosberg et al., 2001 ).
| Decreased activity of glucose-6-phosphate dehydrogenase
Oxidative damage is one of the major risk factors for diabetes.
Glucose-6-phosphate dehydrogenase deficiency predisposes individuals to degenerative diseases such as diabetes and is a major risk factor in the pathogenesis of diabetes. Together, oxidative stress and decreased level of glucose-6-phosphate dehydrogenase caused microvascular complications in diabetic patients (Wan, Tsai, & Chiu, 2002) .
There is a dramatic change in the management of diabetes during the past many thousand years. The existing pharmacological armamentarium applied to manage diabetes has dramatically reduced the morbidity and mortality. However, most of the therapies are long-term use and have serious side effects in many cases (Sanders, 2002) .
Currently, many synthetic drugs are available in the market prescribed for the management of diabetes. The restrictions of these drugs are side effects and postcomplications in the patient. Therefore, it is important to explore the natural products, mostly medicinal plants,
for their beneficial potentials in diabetes therapy. The natural products including medicinal plants have the advantage of having more acceptability toward patients because they are mostly edible and safe to use (Ganesan & Xu, 2017) . Furthermore, medicinal plants have the ability to inhibit many of the enzymes involved in diabetes pathways.
These can be consumed as functional food among the diabetic individuals for treatment. Therefore, this review presents the updated literature revealing the use of natural products as enzyme inhibitors that could be the potential candidate for as phytomedicine for the treatment of diabetes. This review may contribute to set a future direction for search on targets for treatment of diabetes. Moreover, the review purpose to offer basic knowledge for research on the enzymes involved in diabetic pathways, the functions, and working regulation.
| Enzyme inhibitors from natural products
Many studies have taken place to study the behavior of plants extracts and isolated compounds as enzyme inhibitors. Artemisia pallens is an aromatic herb belonging to family Asteraceae. Methanolic extract of aerial parts increased the peripheral utilization of glucose via GLUT4
and also inhibited the intestinal reabsorption of glucose in a dosedependent manner (Subramoniam et al., 1996) .
Myricetin an isolated compound from Abelmoschus moschatus
showed IC 50 of 0.38 mM, inhibiting rat intestinal alpha-glucosidase and porcine alpha-amylase by 29% and 64%, respectively (Tadera, Minami, Takamatsu, & Matsuoka, 2006) .
Bidens pilosa referred as "Black jack" is a perennial flowering plant belonging to family Asteraceae. It showed its effect by protecting pancreatic β cells (Bnouham, Ziyyat, Mekhfi, Tahri, & Legssyer, 2006) . Its methanolic extract inhibited the alpha-glucosidase in vitro (Ezuruike & Prieto, 2014) . Acacia arabica belongs to family Leguminosae and is commonly known as "Babool." Aqueous extract of bark showed 25.2% inhibition of alpha-amylase (Aadil, Barapatre, Rathore, Pottam, & Jha, 2012) .
Aegle marmelos protected against oxidative damage produced by hyperglycemia. Umbelliferone β-D-galactopyranoside an isolated compound from Aegle marmelos raised the hexokinase level at a dose of 10 kg/mg body weight to 112.6 ± 1.77 while decreasing the level of 1,6-fructose biphosphate to 32.2 ± 0.82 at a dose of 40 mg/kg body weight (Kumar et al., 2013) .
Ethanolic and aqueous extract of Acacia catechu showed concentration-dependent inhibition of aldose reductase with the IC 50 of 9.08 and 4.91 1 μg/ml against diabetic lens (Srivastava, Mishra, Bhatia, Narender, & Srivastava, 2011) . Aqueous extract of Agrimonia eupatoria showed IC 50 of 46.31 ± 8.76 μg/ml against alphaglucosidase. It also inhibited the formation of AGEs with the IC 50 of 156.48 μg/ml. Alcoholic extract of dried leaves of Alangium salvifolium inhibited the rat lens aldose reductase with an IC 50 of 106.6 ± 5.11 (Kumar, Pate, Prasad, Sairam, & Hemalatha, 2011) . Allium sativum is commonly known as "Garlic" that belongs to onion family Amaryllidaceae. It showed a dose-dependent inhibitory effect against alpha-glucosidase and aldose reductase with IC 50 greater than 500 mg/ml (Wu, Luo, & Xu, 2015) .
Methanolic extract of the shade-dried bark of cinnamon reduces postprandial intestinal glucose absorption by inhibiting alphaglucosidase with IC 50 of 676 μg/ml while stimulating glucose uptake in the cells via GLUT4 and reduces hyperglycemic response by 42.5% (Shihabudeen, Priscilla, & Thirumurugan, 2011) .
S-methyl cysteine and quercetin from Allium cepa are responsible for inhibition of alpha-glucosidase and lens aldose reductase. IC 50 value for inhibition of alpha-glucosidase is 22.0 ± 1.26 (Wu et al., 2015) . Lyophilized aloe gel from Aloe barbedensis contains aloe-emodin-8-O-glycoside, which enhances glucose transport by modulating the proximal and distal markers involved in glucose uptake and its transformation into glycogen while modulating the expression level of GLUT4 and decreasing the activity of hexokinases . It also inhibited the protein tyrosine phosphatase in a dosedependent manner (Anand et al., 2010) .
Luteolin isolated from Aloe vera Tourn showed inhibition of procaine pancreatic alpha-amylase with IC 50 of 50-500 μg/ml Mishra, Rao, Ojha, Vijayakumar, & Verma, 2010) . Isolated compounds anacardic acids and cardols from Anacardium occidentale are reported to be potent inhibitors of alpha-glucosidases with IC 50 ranging from 1.1-6.1 μM (Toyomizu, Sugiyama, Jin, & Nakatsu, 1993) .
Ethanolic extract of Andrographis paniculata inhibited the alphaglucosidases in a concentration-dependent manner with IC 50 of 17.2 ± 0.15 mg/ml) and a weak alpha-amylase inhibition with IC50 of 50.9 ± 0.17 mg/ml, delaying the absorption of glucose while reducing postprandial hypoglycemia (Subramanian, Asmawi, & Sadikun, 2008) .
The hexane extract of Annona squamosa showed potent inhibition of protein tyrosine phosphate with an IC 50 of 17.4 μg/ml. It also increased the glucose uptake with phosphorylation of insulin receptor substrate 1 (Davis et al., 2012) . Water extract of Averrhoa bilimbi decreased the activity of hepatic glucose 6-phosphatase (Ali, Houghton, & Soumyanath, 2006) and also inhibited the alphaglucosidase and alpha-amylase (Lawag, Aguinaldo, Naheed, & Mosihuzzaman, 2012) . Its diethyl ether extract showed 93% inhibition of protein tyrosine phosphatase (Teng et al., 2011) . Chloroform and methanolic extract of Azadirachta indica at a dose of 100 μg/200 μl in 0.5% dimethyl sulfoxide inhibited intestinal glucosidases by 51%
and 35%, respectively, with an IC 50 of 7.5 mg/ml (Bhat, Kothiwale, Tirmale, Bhargava, & Joshi, 2011) . Aqueous extract of Beta vulgaris lowered the activity of skeletal hexokinases while it raises the level of glucose-6 phosphates by 76.71% when a dose of 200 mg/kg is administered orally (Kabir et al., 2015) . Ethanolic extract of Boerhaavia diffusa inhibited the alpha-glucosidase with an IC 50 of 1.72 μg/ml (Gulati, Harding, & Palombo, 2012) . Capsaicin isolated from Capsicum frutescens showed weak alphaglucosidase inhibition of 48.8% ± 2.8% and inhibited the alphaamylase to 55.5 ± 1.58% (Watcharachaisoponsiri, Sornchan, Charoenkiatkul, & Suttisansanee, 2016) . Quercetin from red pepper
Aqueous extract of
showed an IC 50 of 1.59 μg/ml against alpha-glucosidase (Ranilla, Kwon, Apostolidis, & Shetty, 2010).
Cumin-aldehyde isolated from Carum carvi Linn inhibited the lens aldose reductase with the IC 50 of 0.85 μg/ml and showed weak inhibitory potential for alpha-glucosidase with IC 50 of 0.5 mg/ml (Lee, 2005) . The crude extract of Cassia alata inhibited the alphaglucosidase with an IC 50 of 63.75 ± 2.81 μg/ml whereas Kaempferol 3-O-gentiobioside an isolated compound showed IC 50 of 82.5 ± 13.7 μg/ml (Varghese, Bose, & Habtemariam, 2013) .
Vindolicine and vindolinine isolated from dichloromethane extract of
Catharanthus roseus potently inhibited the protein tyrosine phosphatase with an IC 50 of 11.6 and 14.1 μM, respectively (Tiong et al., 2013) . Ethanolic seed extract of Cassia articulata inhibited the yeast alpha-glucosidase with an IC 50 of 149.6 ± 0.21 μg/ml (Nanumala, Tulasi, & Sujitha, 2015) . Aqueous fruit extract of Embellica officinalis Gaertn showed potent inhibition of rat lens aldose reductase and human recombinant aldose reductase with an IC 50 of 0.72 and 0.88 mg/ml, respectively (Suryanarayana, Kumar, Saraswat, Petrash, & Reddy, 2004) . Aqueous extract of Eucalyptus globulus inhibited the alpha-glucosidase, alphaamylase, Angiotensin-converting enzyme (ACE), and aldose reductase with the IC 50 of 2.08 ± 0.01, 3.01 ± 0.01, 4.31 ± 0.09, and 2.06 ± 0.03, respectively (Dey, Mitra, Katakam, & Singla, 2014) .
Pectin isolated from
Hydrolysable tannins, oenothein C, cornussin B, and swertisin from Eugenia jambolana seeds inhibited the alpha-glucosidase with an IC 50 of 75.1 ± 5.9, 12.2 ± 1.8, and 146.5 ± 1.3 μM, respectively (Omar, Li, Yuan, & Seeram, 2012) . Oral administration of aqueous extract of the bark of Ficus bengalensis Linn at a dose of 500 mg/kg lowered the level of glucokinase to 8.36 ± 1.54 (Gayathri & Kannabiran, 2008) . Ethanolic extract of the fruit of Ficus carica inhibited the alpha-glucosidase and alpha-amylase with an IC 50 of 255.57 ± 36.46 μg/ml and 315.89 ± 3.83 μg/ml, respectively (Mopuri & Islam, 2016) . Licochalcone B and total flavonoids from Glycyrrhiza glabra inhibited intestinal alpha-glucosidase and PTP1B. Licochalcone B showed inhibition of both enzymes with an IC 50 of <0.1 μM and < 0.1 μg/ml, whereas total flavonoids inhibited these enzymes with an IC 50 of 97.33 μM and 15.84 μg/ml, respectively (Guo et al., 2015) . Gymnemic Acid IV from Gymnema sylvestre is responsible for inhibitory activity against yeast alpha-glucosidase with an IC 50 of 68.70 ± 1.22 μg/ml (Chen & Guo, 2017) . Gentiana Olivier showed weak inhibition of alpha-glucosidase with an IC 50 of 0.1982 mg/ml (Orhan, Hoçbaç, Orhan, Asian, & Ergun, 2014) .
Ethanolic extract of Helicteres isora inhibited alpha-glucosidase and sucrose with an IC 50 of 3.71 ± 0.21 and 2.15 ± 0.48, respectively (Rungprom, 2014) . Powdered seeds of Hordeum vulgare showed dosedependent maltase inhibition, and it also inhibited the intestinal alpha-glucosidase with an IC 50 of 79.33 and 18.88 mg/ml, respectively (Ha, Jo, Mannam, Kwon, & Apostolidis, 2016) . Myricetin and Quercetin isolated from Hovenia dulcis inhibited intestinal alpha-glucosidase and alpha-amylase. Myricetin showed an IC 50 of 662 μg/ml against alphaamylase and 3 μg/ml against alpha-glucosidase. Quercetin showed an IC 50 of 770 μg/ml against alpha-amylase and 32 μg/ml against alpha- Zhang, 2012) . Dried leaves of Murraya koeingii inhibited the alphaamylase to 63.28% (Narkhede, 2012 (Sheng et al., 2014) .
Myrtucommulone D and myrtucommulone B isolated from Myrtus communis inhibited alpha-glucosidase with an IC 50 of 84.3 ± 3 and 39.99 ± 1.00, respectively (Önal, Timur, Okutucu, & Zihnioğlu, 2005) .
Flavonoids from Nelumbo nucifera inhibited alpha-amylase and alphaglucosidase with IC 50 of 2.20 ± 0.18 and 1.86 ± 0.018 mg/ml, respectively (Liu et al., 2013) . Silver nanoparticles of Ocimum sanctum have inhibitory potential against alpha-amylase and alpha-glucosidase with IC 50 of 0.70 and 0.009 mg/ml, respectively (Malapermal, Botha, Krishna, & Mbatha, 2017) . Aqueous extract of Ocimum sanctum inhibited the alpha-glucosidase with IC 50 of 26.75 whereas its ethanolic extract showed IC 50 of 230.41 μg/ml (Rege & Chowdhary, 2014) .
Ethanolic leaf extract of Olea europia inhibited the human alphaamylase from saliva and pancreas with an IC 50 of 4 and 0.02 mg/ml, respectively (Komaki et al., 2003) . Oleanolic acid isolated from Olea europia inhibited the pancreatic alpha-amylase with an IC 50 of 0.1 mg/ml (Komaki et al., 2003) . 
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